Journal profile · HEMATOLOGY
Blood Research
ISSN 2287-979X · eISSN 2288-0011 · Korean Society of Hematology
Blood Research: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.7 (journal website); fully open access; APC about USD 2,290; median 82 days to acceptance (97 articles, last 24 months); 71 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Blood Research is published by Korean Society of Hematology and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research and Chronic Lymphocytic Leukemia Research, together about 29.3% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
Blood Research is a peer-reviewed open-access journal that delivers significant clinical, translational and basic study results in hematology and related fields to readers worldwide. Blood Research presents coverage on topics from basic laboratory research to clinical studies, translational studies, and precision medicine in the field of hematology. ScopeResearch articles published in Blood Research cover and include the following categories: Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia, Pediatric Acute Myeloid Leukemia Aplastic Anemia, Immune Thrombocytopenic Purpura Bleeding Disorder, Hemophilia Cell Therapy Chronic Myeloid Leukemia Coagulation Laboratory Histiocytosis Immunology, Infection Laboratory Hematology Lymphoma, CLL Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasm, Other Myeloid Malignancy Pediatric Hematologic Malignancy Red Blood Cell Disorder Thrombotic Disorder Transfusion Medicine, Apheresis
From the journal's Aims & Scope
Research area (LetPub): HEMATOLOGY
Editor-in-chief Yoon HwanPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named South Korea 51, Japan 5, Thailand 5, Singapore 4, India 3 (90 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lymphoma Diagnosis and TreatmentMedicine11%
- Acute Myeloid Leukemia ResearchMedicine11%
- Chronic Lymphocytic Leukemia ResearchMedicine7.3%
- Chronic Myeloid Leukemia TreatmentsMedicine6.2%
- Hematopoietic Stem Cell TransplantationMedicine5.7%
- Myeloproliferative Neoplasms: Diagnosis and TreatmentMedicine5.6%
- Acute Lymphoblastic Leukemia researchMedicine5.2%
- Platelet Disorders and TreatmentsMedicine5.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 3.7Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.4Publisher website ·
- CiteScore 2026-06
- 4.9LetPub ·
- SJR 2026-06
- 0.92LetPub ·
- SNIP 2026-06
- 1.52LetPub ·
- h-index
- 41OpenAlex ·
- i10-index
- 268OpenAlex ·
- 2-year mean citedness
- 2.98OpenAlex ·
- Self-citation rate
- 8.1%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 57LetPub ·
- Downloads per year (publisher) 2025
- 153,200Publisher website ·
Articles by year OpenAlex count · 1,115 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 53 | 53 | 19 |
| 2025 | 71 | 71 | 163 |
| 2024 | 46 | 46 | 324 |
| 2023 | 65 | 65 | 398 |
| 2022 | 73 | 73 | 763 |
| 2021 | 74 | 74 | 632 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
82 daysMedian, submission to acceptance · P25–P75 62 days – 118 days
- Acceptance to online
- median 21 days (97 articles)
- Submission to online
- median 110 days
- Sample
- 97 articles with submission and acceptance dates (140 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 13 daysPublisher website ·
- Submission to publication (journal-reported)
- about 15 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | GBP 1,590 / USD 2,290 / EUR 1,890 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,290 / EUR 1,890 / GBP 1,590 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare5 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 3,500 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted6, with length limits
- brief communicationBlood Research accepts submissions of the following article types: ResearchIs a manuscript containing results of clinical, laboratory, or experimental investiga…Length not stated
- commentaryBlood Research accepts submissions of the following article types: ResearchIs a manuscript containing results of clinical, laboratory, or experimental investiga…Length not stated
- editorialBlood Research accepts submissions of the following article types: ResearchIs a manuscript containing results of clinical, laboratory, or experimental investiga…Length not stated
- letterBlood Research accepts submissions of the following article types: ResearchIs a manuscript containing results of clinical, laboratory, or experimental investiga…main text ≤ 1,500 words
- researchResearch Is a manuscript containing results of clinical, laboratory, or experimental investigations.Length not stated
- reviewBlood Research accepts submissions of the following article types: ResearchIs a manuscript containing results of clinical, laboratory, or experimental investiga…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Competing Interests
Competing interests disclosure required. Model summary
Authors are requested to disclose interests that are directly or indirectly related to the work submitted for publication. Interests within the last 3 years of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 3-year time frame must be disclosed if they could reasonably be perceived as influencing the submitted work. Disclo…
Source ↗Publisher website ·- Data availability Data availability
Data availability statement required for all original research. Model summary
All original research must include a data availability statement. Data availability statements should include information on where data supporting the results reported in the article can be found, if applicable. Statements should include, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. For the purposes of the data availability statement, “data” is…
Source ↗Publisher website ·- License & copyright Copyright
Articles in Springer Nature open access journals do not require transfer of copyright as the copyright remains with the author. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
Copyright remains with authors. Model summary
To find out more about publishing your work Open Access in Blood Research, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review Single-blind peer review
Authors may suggest or exclude reviewers. Model summary
This journal follows a single-blind reviewing procedure. This journal also publishes special/guest-edited issues. The peer review process for these articles is the same as the peer review process of the journal in general. Additionally, if a guest editor authors an article in their issue/collection, they will not handle the peer review process.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Korean Society of Hematology
- ISSN
- 2287-979X
- Electronic ISSN
- 2288-0011
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Blood Research
What CAS zone is Blood Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Blood Research is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Blood Research?
The journal's website gives an impact factor of 3.7 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 4.9, h-index 41.
How long does peer review take at Blood Research?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 82 days (interquartile range 62–118 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Blood Research?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 3,500 words; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Blood Research based?
Of the 90 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are South Korea (51), Japan (5) and Thailand (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Blood Research?
According to LetPub and DOAJ records, Blood Research is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Embase and CAS; that list has not been checked against each database.
Is Blood Research open access, and what is the APC?
Blood Research is a fully open-access journal. APC about USD 2,290.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .